CD83 and graft versus host disease: Notably, use of CD83-targeted T cells in humanised mice also revealed a role for human CD1c+CD83+ and CD1c+MHC class II+ DCs in GVHD progression, providing the first evidence that donor human DCs can contribute to GVHD development in humanised mice [101].